Scott Andrew Smith
Net Worth
Last updated:
What is Scott Andrew Smith net worth?
The estimated net worth of Mr. Scott Andrew Smith is at least $5,000,162 as of 2 Dec 2021. He owns shares worth $131,372 as insider, has earned $1,570,750 from insider trading and has received compensation worth at least $3,298,040 in BioAtla, Inc..
What is the salary of Scott Andrew Smith?
Mr. Scott Andrew Smith salary is $824,510 per year as Pres & Director in BioAtla, Inc..
How old is Scott Andrew Smith?
Mr. Scott Andrew Smith is 63 years old, born in 1962.
What stocks does Scott Andrew Smith currently own?
As insider, Mr. Scott Andrew Smith owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| BioAtla, Inc. (BCAB) | Pres & Director | 345,715 | $0.38 | $131,372 |
What does BioAtla, Inc. do?
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.
Scott Andrew Smith insider trading
BioAtla, Inc.
Mr. Scott Andrew Smith has made 9 insider trades in 2021, according to the Form 4 filled with the SEC. Most recently he sold 2,984 units of BCAB stock worth $65,964 on 2 Dec 2021.
The largest trade he's ever made was exercising 33,244 units of BCAB stock on 26 Aug 2021. As of 2 Dec 2021 he still owns at least 345,715 units of BCAB stock.
BioAtla key executives
BioAtla, Inc. executives and other stock owners filed with the SEC:
- Dr. Jay M. Short (67) Co-Founder, Chief Executive Officer & Chairman
- Mr. Scott Andrew Smith (63) Pres & Director